Press release
Chronic Obstructive Pulmonary Disease (COPD) Treatment Device Market Forecast to Reach USD 25.4 Billion by 2034
Chronic Obstructive Pulmonary Disease (COPD) Treatment Device
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71513
COPD management heavily relies on treatment devices such as inhalers, nebulizers, oxygen therapy devices, and non-invasive ventilation systems, which provide symptomatic relief and improve quality of life. With the rising prevalence of smoking, exposure to pollutants, and aging populations, demand for COPD treatment devices is accelerating. Between 2024 and 2034, the market is projected to grow significantly, driven by technological innovation, digital health integration, and expanding patient access to advanced respiratory care.
Market Overview
The global COPD treatment device market size is estimated at USD 12.8 billion in 2024 and is forecast to reach USD 25.4 billion by 2034, growing at a CAGR of 7.2%.
Key highlights:
• Increasing prevalence of COPD, particularly in aging populations.
• Rising adoption of portable oxygen concentrators and digital inhalers.
• Growing role of telehealth and remote patient monitoring in COPD management.
• Strong uptake of home-based care devices due to convenience and cost-effectiveness.
• North America and Europe dominate in revenue, while Asia-Pacific emerges as the fastest-growing region.
Market Segmentation
By Product
• Inhalers (Dry Powder Inhalers, Metered Dose Inhalers)
• Nebulizers
• Oxygen Therapy Devices (Portable Oxygen Concentrators, Cylinders)
• Non-Invasive Ventilation Devices
• Others
By Technology
• Portable Devices
• Digital Health-Enabled Devices (Smart Inhalers, Connected Nebulizers)
• Conventional Devices
By Platform
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
By End Use
• Hospitals & Specialty Clinics
• Ambulatory Surgical Centers
• Homecare Settings
By Application
• Chronic Bronchitis
• Emphysema
• Asthma-COPD Overlap Syndrome (ACOS)
• Others
Summary of Segmentation
Inhalers and nebulizers account for the largest market share due to their widespread use in frontline COPD management. However, portable oxygen therapy and digital health-enabled devices are expected to see the fastest growth, fueled by patient demand for convenience, adherence monitoring, and remote healthcare integration.
Explore Full Report here: https://exactitudeconsultancy.com/reports/71513/chronic-obstructive-pulmonary-disease-treatment-device-market
Regional Analysis
North America
• Largest market in 2024, driven by high COPD prevalence, advanced respiratory care infrastructure, and adoption of digital inhalers.
• Strong reimbursement policies and robust presence of leading device manufacturers.
Europe
• Second-largest market, supported by aging demographics and government-led initiatives for respiratory care.
• Countries such as Germany, the UK, and France contribute significantly to adoption of homecare oxygen therapy devices.
Asia-Pacific
• Fastest-growing region between 2024 and 2034.
• Rising prevalence of COPD in China and India due to smoking, air pollution, and occupational exposures.
• Increasing healthcare investments and availability of low-cost inhalers and oxygen concentrators.
Middle East & Africa
• Gradual growth supported by improved access to tertiary care hospitals.
• Rising awareness programs in urban centers are improving diagnosis and treatment uptake.
Latin America
• Brazil and Mexico dominate the regional market, supported by expanding healthcare access and higher adoption of inhalation therapy.
Regional Summary
While North America and Europe continue to lead the market, Asia-Pacific will be the key growth driver through 2034, thanks to its expanding patient population and improving affordability of advanced devices.
Market Dynamics
Growth Drivers
• Rising global prevalence of COPD due to smoking and pollution.
• Increasing demand for portable and digital treatment devices.
• Expanding homecare segment due to convenience and cost efficiency.
• Government initiatives and reimbursement support for respiratory disease management.
Key Challenges
• High cost of advanced devices, limiting adoption in low-income countries.
• Device misuse and poor patient adherence to therapy.
• Limited healthcare infrastructure in rural areas of emerging economies.
Latest Trends
• Smart inhalers and connected devices for real-time monitoring of adherence and usage patterns.
• Portable oxygen concentrators gaining strong demand among elderly and homecare patients.
• Telemedicine integration for COPD management and remote care.
• Use of artificial intelligence (AI) in monitoring respiratory patterns and predicting exacerbations.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=71513
Competitive Landscape
Major Players
• Philips Respironics
• ResMed Inc.
• Medtronic plc
• Fisher & Paykel Healthcare
• GlaxoSmithKline plc (device-integrated therapies)
• Teva Pharmaceutical Industries Ltd.
• AstraZeneca plc (connected inhalers)
• Boehringer Ingelheim
• Drive DeVilbiss Healthcare
• Vyaire Medical
• 3M Health Care
• Omron Healthcare, Inc.
• GE Healthcare
Competition Summary
The COPD treatment device market is moderately fragmented, with strong participation from both multinational corporations and regional players. Philips, ResMed, and Medtronic dominate the respiratory device space, while pharma-device partnerships (e.g., AstraZeneca, GSK with smart inhalers) are reshaping the competitive landscape. Strategies such as product innovation, digital health integration, and expansion into emerging economies are key to sustaining market leadership.
Conclusion
The chronic obstructive pulmonary disease treatment device market is poised for substantial growth through 2034, fueled by rising prevalence, rapid technological advancements, and increasing demand for portable and digital solutions.
While cost and adherence challenges remain, the integration of telehealth, AI, and connected devices is redefining COPD management. Companies that focus on patient-centric innovation, affordability, and strategic partnerships will be best positioned to capture opportunities in this evolving market.
Key Takeaways:
• COPD prevalence continues to rise, driving demand for treatment devices.
• Inhalers and nebulizers dominate today, but portable oxygen concentrators and smart devices are the fastest-growing categories.
• North America and Europe lead adoption, while Asia-Pacific shows the highest growth potential.
• Competitive advantage will depend on digital innovation, affordability, and expansion into emerging markets.
This report is also available in the following languages : Japanese (慢性閉塞性肺疾患治療デバイス市場), Korean (만성 폐쇄성 폐질환 치료 기기 시장), Chinese (慢性阻塞性肺病治疗设备市场), French (Marché des dispositifs de traitement de la bronchopneumopathie chronique obstructive), German (Markt für Geräte zur Behandlung chronisch obstruktiver Lungenerkrankungen), and Italian (Mercato dei dispositivi per il trattamento della broncopneumopatia cronica ostruttiva), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/71513/chronic-obstructive-pulmonary-disease-treatment-device-market#request-a-sample
Our More Reports:
Infantile Spasm Market
https://exactitudeconsultancy.com/reports/71941/infantile-spasm-market
Inflammatory Pain Market
https://exactitudeconsultancy.com/reports/71942/inflammatory-pain-market
Intracerebral Hemorrhage Market
https://exactitudeconsultancy.com/reports/71943/intracerebral-hemorrhage-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Obstructive Pulmonary Disease (COPD) Treatment Device Market Forecast to Reach USD 25.4 Billion by 2034 here
News-ID: 4170336 • Views: …
More Releases from Exactitude Consultancy
SSG Hospital launches an AI-powered oncology chatbot
The global AI in Oncology Market is rapidly emerging as one of the most transformative frontiers in healthcare, combining advanced machine learning, big data analytics, and clinical expertise to fight cancer. With oncology representing one of the most complex medical domains, artificial intelligence (AI) is reshaping how clinicians detect, diagnose, and treat cancer. AI is accelerating drug discovery, enhancing diagnostic imaging, enabling personalized treatment recommendations, and improving patient monitoring. As…
Orion and Abilita Therapeutics Announce Research Partnership to Create Next-Gene …
The global Next-Generation Antibody Therapeutics Market is experiencing rapid growth as pharmaceutical and biotechnology companies push the boundaries of antibody engineering to deliver safer, more effective, and highly targeted therapies. Unlike conventional monoclonal antibodies, next-generation formats-such as bispecific antibodies, antibody-drug conjugates (ADCs), antibody fragments, and engineered scaffolds-offer enhanced specificity, improved pharmacokinetics, and novel mechanisms of action. These innovations are revolutionizing treatment landscapes in oncology, autoimmune disorders, infectious diseases, and rare…
Prospects for the NAMPT Inhibitors Market in 2025-2034 | Pfizer Inc., Novartis A …
The NAMPT (Nicotinamide Phosphoribosyltransferase) Inhibitor Market is gaining momentum as researchers and biopharmaceutical companies explore novel therapeutic strategies targeting cellular metabolism and inflammatory pathways. NAMPT, a key enzyme in the NAD+ biosynthesis pathway, has been implicated in cancer cell survival, immune regulation, and metabolic disorders. Inhibitors of NAMPT have emerged as promising candidates for oncology, autoimmune conditions, and age-related diseases. With clinical trials expanding and increasing R&D investments, the NAMPT…
Acute lymphoblastic leukemia: a comprehensive review and 2025 latest update
Introduction
Acute lymphoblastic leukemia (ALL) is an aggressive cancer of the blood and bone marrow that primarily affects white blood cell precursors. While relatively rare compared to other cancers, it is the most common type of cancer in children, though it also affects adults, where prognosis is often poorer.
The management of ALL has improved significantly in recent decades due to advances in chemotherapy regimens, targeted therapies, and immunotherapies such as CAR-T…
More Releases for COPD
Copd Drugs Market Size Analysis by Application, Type, and Region: Forecast to Co …
USA, New Jersey- According to Market Research Intellect, the global Copd Drugs market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
Because respiratory problems are becoming more common worldwide, especially among smokers and older populations, the market for COPD medications is expanding steadily. The need…
Chronic Obstructive Pulmonary Disease (COPD) Treatment Market 2024-2030 Growth: …
Growth: Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Insights :
For stakeholders, an optimistic view is shown by the thorough study of the worldwide "Chronic Obstructive Pulmonary Disease (COPD) Treatment market". The research provides specifics on the market's historical and present conditions as well as projected trends and size. Decision-makers may navigate the competitive environment and investment possibilities in the Chronic Obstructive Pulmonary Disease (COPD) Treatment market with the use of…
Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market - Breathing Sol …
Newark, New Castle, USA - new report, titled Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Obstructive Pulmonary Disease (COPD) Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Obstructive Pulmonary Disease…
Asthma & COPD Drugs Market - Breathe Freely, Live Fully: Empowering Respiratory …
Newark, New Castle, USA - new report, titled Asthma & COPD Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Asthma & COPD Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Asthma & COPD Drugs market. The report offers…
Copd CBD Gummies: Reviews (Shocking Facts) Copd CBD Oil "Ingredients" Pain Relie …
Copd CBD Gummies: With the increasing need for both individual and expert degrees, the stress and also stress are also enhancing. Individuals are using various methods to fight it. However, as a result of much less time for self, it is really hard. Here the natural herbs and supplements have actually discovered their way into our lives. The Copd CBD Oil are instances of super-effective natural supplements. The CBD existing…
Power Harmonica to Cure Chronic Asthma & COPD
Power Harmonica is a free reed wind musical instrument. It is small rectangular shaped musical instrument. It has 48 number of holes which makes it special and different from other harmonica's.
It's a pocket-friendly musical instrument. Power Harmonica is used as a natural treatment for many types of lung disorders and has no side effects. To play Power Harmonica there is no need of having a musical background it can be…
